Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
US Government Reportedly Preparing New Tariffs on Certain Pharmaceutical Companies
Recommend 5 Positive 2 Negative 6 |
||||
|
||||
|
Bloomberg, citing sources, reported that the US government is set to announce as soon as Thursday (2nd) the imposition of tariffs on pharmaceutical companies that have not met minimum drug price requirements, marking the latest move to levy duties on imported goods on national security grounds. Over the past year, US President Donald Trump has repeatedly threatened to impose tariffs of 100% to 200% on drugmakers in an effort to force pharmaceutical companies to relocate production back to the US and lower domestic drug prices. Most major pharmaceutical companies, including Pfizer (PFE.US) and Eli Lilly (LLY.US), have reached agreements with the White House in exchange for exemptions from such tariffs for three years. Companies that have neither reached agreements with the White House nor engaged in negotiations are reportedly set to face tariffs of 100%, although certain drugs and disease categories may be granted exemptions. (mn/w) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
